Bortezomib (velcade) in combo scores for initial myeloma treatment
September 1st, 2008 by 
admin SALAMANCA, Espana (MedPage Today) — For binary myeloma patients disqualified for high-dose chemotherapy, bortezomib (Velcade) appears trenchant as a first-line therapy when additional to accepted antineoplastic (Alkeran) and prednisone, institute a form threesome trial. (Source: MedPage Today Hematology/Oncology)
Tags: ATM, chemotherapy
Posted in Cancer | 